awmsg logo



mycophenolic acid (Myfortic®)


Reference No. 210

Publication date:
13/06/2006


Appraisal information

mycophenolic acid (Myfortic®) tablet


Company: Novartis Pharmaceuticals UK Ltd
BNF category: Malignant disease and immunosupression
NMG meeting date: Not scheduled
AWMSG meeting date: 02/03/2006
   
   
Submission Type: Full Submission
Status: Superseded
Advice No: Not available
Ministerial ratification: 07/06/2006

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

AWMSG ADVICE SUPERSEDED BY NICE GUIDANCE (ID456) NICE GUIDANCE ISSUED SEPTEMBER 2017 (Refer to NICE website for full guidance on NICE recommendations, including any specific restrictions on the use of the technology)
Final Appraisal Recommendation (FAR)
Download